Phibro Animal Health (PAHC) Capital Expenditures (2013 - 2026)

Phibro Animal Health's Capital Expenditures history runs 14 years deep, the most recent figure standing at $15.3 million for Q1 2026.

• In Q1 2026, Capital Expenditures rose 97.73% year-over-year to $15.3 million; the TTM figure through Mar 2026 stood at $53.4 million (up 8334.72% YoY), while the FY2025 annual figure was $38.3 million, up 1517.79% from the prior year.
• Capital Expenditures was $15.3 million for Q1 2026 at Phibro Animal Health, up from $11.1 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $23.2 million in Q3 2022 to a low of -$25.8 million in Q2 2024.
• Historically, Capital Expenditures has averaged $9.1 million across 5 years, with a median of $10.0 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Capital Expenditures jumped 211.13% in 2022, then sank 336.88% in 2024.
• A 5-year view of Capital Expenditures shows it stood at $9.8 million in 2022, then gained by 11.61% to $11.0 million in 2023, then slipped by 28.62% to $7.8 million in 2024, then jumped by 41.87% to $11.1 million in 2025, then surged by 38.02% to $15.3 million in 2026.
• The last three Capital Expenditures figures came in at $15.3 million (Q1 2026), $11.1 million (Q4 2025), and $13.8 million (Q3 2025), per Business Quant data.